Perioperative Chemotherapy with FLOT Improves Survival Among Patients with Resectable Oesophageal Adenocarcinoma By Ogkologos - February 10, 2025 721 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ESOPEC study Source RELATED ARTICLESMORE FROM AUTHOR ESMO Strengthens Global Oncology Collaboration Through its Growing Presence in the Asia-Pacific Pemigatinib Prolongs mPFS Over Chemotherapy in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements FDA Approves Atezolizumab for Adjuvant Treatment of Muscle Invasive Bladder Cancer in Patients with Molecular Residual Disease MOST POPULAR What Are Clinical Practice Guidelines and How Do They Impact Care... May 27, 2022 FDA Proposes Changes to Mammography Standards to Inform Women About Breast... March 28, 2019 Second-line Sintilimab Improves Survival Over Docetaxel in Squamous Non-Small Cell Lung... December 11, 2020 Young Adult Cancer Awareness Week: Recognizing Adolescent and Young Adults Cancer... April 5, 2021 Load more HOT NEWS Venetoclax-Obinutuzumab With or Without Ibrutinib Is Superior to Chemoimmunotherapy in First-Line... Getting Help for Sexual Health Problems When You Have Head and... Treatment for Oropharyngeal Cancer: Investigating Ways to Do Less Harm First Study to Demonstrate that PD1 Immune Checkpoint Blockade May Yield...
